Dyne Total Assets from 2010 to 2024
DYN Stock | USD 27.68 1.07 3.72% |
Total Assets | First Reported 2007-06-30 | Previous Quarter 165.1 M | Current Value 522.3 M | Quarterly Volatility 5.6 B |
Check Dyne TherapeuticsInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dyne main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.3 M, Interest Expense of 2.5 M or Selling General Administrative of 29.8 M, as well as many exotic indicators such as Price To Sales Ratio of 6.54, Dividend Yield of 0.0 or PTB Ratio of 9.13. Dyne financial statements analysis is a perfect complement when working with Dyne TherapeuticsInc Valuation or Volatility modules.
Dyne | Total Assets |
Latest Dyne TherapeuticsInc's Total Assets Growth Pattern
Below is the plot of the Total Assets of Dyne TherapeuticsInc over the last few years. Total assets refers to the total amount of Dyne TherapeuticsInc assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Dyne TherapeuticsInc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Dyne TherapeuticsInc's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dyne TherapeuticsInc's overall financial position and show how it may be relating to other accounts over time.
View | Last Reported 165.08 M | 10 Years Trend |
|
Total Assets |
Timeline |
Dyne Total Assets Regression Statistics
Arithmetic Mean | 5,080,062,393 | |
Geometric Mean | 1,100,848,989 | |
Coefficient Of Variation | 108.07 | |
Mean Deviation | 4,750,216,752 | |
Median | 4,127,000,000 | |
Standard Deviation | 5,490,108,096 | |
Sample Variance | 30141286.9T | |
Range | 13.2B | |
R-Value | (0.65) | |
Mean Square Error | 18607297T | |
R-Squared | 0.43 | |
Significance | 0.01 | |
Slope | (801,968,906) | |
Total Sum of Squares | 421978016.7T |
Dyne Total Assets History
Other Fundumenentals of Dyne TherapeuticsInc
Dyne TherapeuticsInc Total Assets component correlations
Click cells to compare fundamentals
About Dyne TherapeuticsInc Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Dyne TherapeuticsInc income statement, its balance sheet, and the statement of cash flows. Dyne TherapeuticsInc investors use historical funamental indicators, such as Dyne TherapeuticsInc's Total Assets, to determine how well the company is positioned to perform in the future. Although Dyne TherapeuticsInc investors may use each financial statement separately, they are all related. The changes in Dyne TherapeuticsInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Dyne TherapeuticsInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Dyne TherapeuticsInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Dyne TherapeuticsInc. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Total Assets | 165.1 M | 156.8 M | |
Intangibles To Total Assets | 0.06 | 0.04 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Dyne TherapeuticsInc Correlation against competitors. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne TherapeuticsInc guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for Dyne Stock analysis
When running Dyne TherapeuticsInc's price analysis, check to measure Dyne TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dyne TherapeuticsInc is operating at the current time. Most of Dyne TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Dyne TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dyne TherapeuticsInc's price. Additionally, you may evaluate how the addition of Dyne TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
CEOs Directory Screen CEOs from public companies around the world | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |
Is Dyne TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dyne TherapeuticsInc. If investors know Dyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dyne TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.98) | Return On Assets (0.41) | Return On Equity (0.71) |
The market value of Dyne TherapeuticsInc is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Dyne TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dyne TherapeuticsInc's market value can be influenced by many factors that don't directly affect Dyne TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dyne TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dyne TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dyne TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.